Pulmonary Vasodilators and Anesthesia Considerations
Copyright © 2017 Elsevier Inc. All rights reserved..
Pulmonary hypertension (PH) is a complex disease process of the pulmonary vasculature system characterized by elevated pulmonary arterial pressures. Patients with PH are at increased risk for morbidity and mortality, including intraoperatively and postoperatively. Appreciation by the clinical anesthesiologist of the pathophysiology of PH is warranted. Careful and meticulous strategy using appropriate anesthetic medications, pulmonary vasodilator and inotropic agents, and careful fluid management all increase the likelihood of the best possible outcome in this challenging patient population.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Anesthesiology clinics - 35(2017), 2 vom: 19. Juni, Seite 221-232 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Green, Jeremy B [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
31C4KY9ESH |
|---|
| Anmerkungen: |
Date Completed 06.11.2017 Date Revised 02.12.2018 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.anclin.2017.01.008 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM272083933 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM272083933 | ||
| 003 | DE-627 | ||
| 005 | 20231224234115.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.anclin.2017.01.008 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0906.xml |
| 035 | |a (DE-627)NLM272083933 | ||
| 035 | |a (NLM)28526144 | ||
| 035 | |a (PII)S1932-2275(17)30013-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Green, Jeremy B |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pulmonary Vasodilators and Anesthesia Considerations |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.11.2017 | ||
| 500 | |a Date Revised 02.12.2018 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2017 Elsevier Inc. All rights reserved. | ||
| 520 | |a Pulmonary hypertension (PH) is a complex disease process of the pulmonary vasculature system characterized by elevated pulmonary arterial pressures. Patients with PH are at increased risk for morbidity and mortality, including intraoperatively and postoperatively. Appreciation by the clinical anesthesiologist of the pathophysiology of PH is warranted. Careful and meticulous strategy using appropriate anesthetic medications, pulmonary vasodilator and inotropic agents, and careful fluid management all increase the likelihood of the best possible outcome in this challenging patient population | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Anesthesia | |
| 650 | 4 | |a Calcium channel blockers | |
| 650 | 4 | |a Endothelin antagonists | |
| 650 | 4 | |a Inhaled nitric oxide | |
| 650 | 4 | |a Prostacyclin | |
| 650 | 4 | |a Pulmonary hypertension | |
| 650 | 7 | |a Vasodilator Agents |2 NLM | |
| 650 | 7 | |a Nitric Oxide |2 NLM | |
| 650 | 7 | |a 31C4KY9ESH |2 NLM | |
| 700 | 1 | |a Hart, Brendon |e verfasserin |4 aut | |
| 700 | 1 | |a Cornett, Elyse M |e verfasserin |4 aut | |
| 700 | 1 | |a Kaye, Alan D |e verfasserin |4 aut | |
| 700 | 1 | |a Salehi, Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Fox, Charles J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Anesthesiology clinics |d 2006 |g 35(2017), 2 vom: 19. Juni, Seite 221-232 |w (DE-627)NLM160807263 |x 1932-2275 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2017 |g number:2 |g day:19 |g month:06 |g pages:221-232 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.anclin.2017.01.008 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 2017 |e 2 |b 19 |c 06 |h 221-232 | ||